Semanteon Capital Management LP Buys New Shares in The Clorox Company $CLX

Semanteon Capital Management LP bought a new position in The Clorox Company (NYSE:CLX) in the 2nd quarter, HoldingsChannel.com reports. The fund bought 11,013 shares of the company’s stock, valued at approximately $1,322,000. Clorox makes up approximately 2.0% of Semanteon Capital Management LP’s investment portfolio, making the stock its 20th largest position.

Several other hedge funds have also added to or reduced their stakes in the business. American National Bank & Trust boosted its position in Clorox by 69.5% during the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after buying an additional 89 shares during the period. NewSquare Capital LLC grew its position in Clorox by 567.6% during the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after acquiring an additional 193 shares during the last quarter. Ransom Advisory Ltd bought a new position in Clorox during the 1st quarter worth approximately $35,000. Hantz Financial Services Inc. purchased a new position in Clorox in the 2nd quarter worth approximately $31,000. Finally, GW&K Investment Management LLC lifted its position in Clorox by 239.1% in the first quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock valued at $43,000 after purchasing an additional 208 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on CLX shares. JPMorgan Chase & Co. cut their price target on shares of Clorox from $127.00 to $120.00 and set a “neutral” rating on the stock in a report on Tuesday, November 4th. Morgan Stanley reduced their target price on Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. Bank of America cut their price target on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. Wells Fargo & Company cut their target price on shares of Clorox from $125.00 to $117.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. Finally, Rothschild & Co Redburn reduced their price target on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. One research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Reduce” and an average target price of $125.69.

Insider Activity at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.63% of the stock is owned by company insiders.

Clorox Price Performance

CLX stock opened at $103.52 on Monday. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The firm has a 50 day moving average price of $117.67 and a 200-day moving average price of $123.48. The Clorox Company has a 52-week low of $103.43 and a 52-week high of $171.37. The firm has a market capitalization of $12.63 billion, a price-to-earnings ratio of 15.88, a PEG ratio of 0.92 and a beta of 0.52.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $0.07. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. During the same quarter in the previous year, the firm earned $1.86 EPS. Clorox’s quarterly revenue was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd were paid a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date was Wednesday, October 22nd. Clorox’s payout ratio is currently 77.86%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.